Biotech Shares Surge Following Positive Clinical Trial Announcements
Shares of several biotechnology firms rallied after announcing successful clinical trial outcomes, including Pharvaris’s late-stage hereditary angioedema study and Roivant’s Phase 2 results. The positive data also highlighted progress in aging research from Genflow Biosciences.